Study of Pembrolizumab + Pemetrexed + Platinum Chemotherapy With or Without Zoldonrasib as First Line Treatment in Metastatic Non-squamous RAS G12D-Mutated NSCLC
Trial details
- Registry ID
- NCT07777822
- Drugs studied
- pembrolizumab, pemetrexed + cisplatin /carboplatin, zoldonrasib